The challenge of multiple cardiovascular risk factor control outside Western Europe: Findings from the International

Dirk J Blom1, Raul D Santos2, Veronique Daclin3

  • 1University of Cape Town, Cape Town, South Africa.

Insights

Achieving control of multiple cardiovascular risk factors like LDL-C, diabetes, and blood pressure is challenging for high-risk patients globally. Poor control of one factor often correlates with inadequate management of others, highlighting a significant public health concern.

Area of Science:

  • Cardiology
  • Public Health
  • Endocrinology

Background:

  • Comprehensive control of cardiovascular risk factors is crucial for reducing cardiovascular events.
  • Simultaneous management of multiple risk factors remains a significant clinical challenge worldwide.
  • Current guidelines emphasize aggressive risk factor modification for high-risk individuals.

Purpose of the Study:

  • To investigate the achievement of guideline-recommended low-density lipoprotein cholesterol (LDL-C) targets in patients on lipid-modifying therapy.
  • To examine the rate of, and associations between, simultaneous control of multiple cardiovascular risk factors (LDL-C, diabetes, hypertension) in high-risk patients.
  • To assess risk factor control across different countries outside Western Europe.

Main Methods:

  • A multinational, cross-sectional, observational study involving 2377 patients with dyslipidaemia, diabetes, and hypertension.
  • Data collection on patient demographics, comorbidities (metabolic syndrome, obesity, atherosclerotic disease), cardiovascular risk stratification, and lifestyle factors (smoking, BMI).
  • Analysis of the achievement of European Society of Cardiology (ESC)/European Atherosclerosis Society (EAS) guideline targets for LDL-C, blood pressure, and diabetes control.

Main Results:

  • Only 12.2% of high-risk patients achieved simultaneous control of LDL-C, diabetes, and blood pressure.
  • Individual target achievement rates were 43.9% for LDL-C, 55.5% for blood pressure, and 39.3% for diabetes.
  • Multiple correspondence analysis revealed associations between the control of LDL-C, blood pressure, diabetes, BMI, and smoking status.

Conclusions:

  • Comprehensive control of multiple cardiovascular risk factors in high-risk patients is suboptimal globally.
  • Failure to control one modifiable risk factor is significantly associated with poor control of other risk factors.
  • Interventions targeting simultaneous risk factor management are essential to improve cardiovascular outcomes in high-risk populations.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
334
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
592
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
1.3K
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
561
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
291
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
241